Immunology and allergy clinics of North AmericaHumansDermatitisAtopicNetherlandsJanus Kinase Inhibitors
Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands.
Anne R Schlösser, A C M Lia Kunkeler, Dirk Jan Hijnen
Published: 202510.1016/j.iac.2025.06.008
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by severe itch, significantly affecting patients' quality of life. Increased understanding of the underlying pathomechanism has led to the development of effective new system…
Preview only. Read the full abstract at the source